Literature DB >> 22850212

Selected chromone derivatives as inhibitors of monoamine oxidase.

Lesetja J Legoabe1, Anél Petzer, Jacobus P Petzer.   

Abstract

A previous study has shown that a series of C6-benzyloxy substituted chromones exhibit high binding affinities for human monoamine oxidase (MAO) B. In an attempt to discover additional chromones with potent and selective MAO-B inhibitory potencies and to further examine the structure-activity relationships of MAO-B inhibition by chromones, the series was expanded with homologues containing polar functional groups on C3 of the chromone ring. The results demonstrate that 6-[(3-bromobenzyl)oxy]chromones containing acidic and aldehydic functional groups on C3 act as potent reversible MAO-B inhibitors with IC(50) values of 2.8 and 3.7 nM, respectively. Interestingly, a 2-hydroxy-2,3-dihydro-1-benzopyran-4-one derivative as well as open-ring 2-acetylphenol analogues of the chromones also were potent MAO-B inhibitors with IC(50) values ranging from 4 to 11 nM. Chromone derivatives containing the benzyloxy substituent on C5 of the chromone ring, however, exhibit MAO-B inhibition potencies that are several orders of magnitude weaker. High potency inhibitors of MAO-B may find application in the therapy of neurodegenerative disorders such as Parkinson's disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850212     DOI: 10.1016/j.bmcl.2012.07.025

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors.

Authors:  Jin-Shuai Lan; Tong Zhang; Yun Liu; Yong Zhang; Jian-Wei Hou; Sai-Sai Xie; Jing Yang; Yue Ding; Zhen-Zhen Cai
Journal:  Medchemcomm       Date:  2017-01-05       Impact factor: 3.597

2.  Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.

Authors:  Xiao-Bing Wang; Fu-Cheng Yin; Ming Huang; Neng Jiang; Jin-Shuai Lan; Ling-Yi Kong
Journal:  RSC Med Chem       Date:  2020-01-07

Review 3.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

4.  Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase.

Authors:  Annah N Mpitimpiti; Jacobus P Petzer; Anél Petzer; Johannes H L Jordaan; Anna C U Lourens
Journal:  Mol Divers       Date:  2019-01-21       Impact factor: 2.943

5.  2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.

Authors:  Lesetja J Legoabe; Anél Petzer; Jacobus P Petzer
Journal:  Drug Des Devel Ther       Date:  2015-07-15       Impact factor: 4.162

6.  Crystal structure of 4-oxo-4H-chromene-3-carb-oxy-lic acid.

Authors:  Yoshinobu Ishikawa
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-07-17

7.  Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.

Authors:  Irene Pachón-Angona; Bernard Refouvelet; Rudolf Andrýs; Helène Martin; Vincent Luzet; Isabel Iriepa; Ignacio Moraleda; Daniel Diez-Iriepa; María-Jesús Oset-Gasque; José Marco-Contelles; Kamil Musilek; Lhassane Ismaili
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.